- Home
- AVXL vs HSTM Comparison
AVXL vs HSTM Comparison
Compare AVXL & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVXL
- HSTM
- Stock Information
- Founded
- AVXL 2004
- HSTM 1990
- Country
- AVXL United States
- HSTM United States
- Employees
- AVXL N/A
- HSTM N/A
- Industry
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- HSTM Computer Software: Programming Data Processing
- Sector
- AVXL Health Care
- HSTM Technology
- Exchange
- AVXL Nasdaq
- HSTM Nasdaq
- Market Cap
- AVXL 956.7M
- HSTM 828.5M
- IPO Year
- AVXL N/A
- HSTM 2000
- Fundamental
- Price
- AVXL $9.95
- HSTM $26.49
- Analyst Decision
- AVXL Strong Buy
- HSTM Hold
- Analyst Count
- AVXL 2
- HSTM 2
- Target Price
- AVXL $44.00
- HSTM $28.00
- AVG Volume (30 Days)
- AVXL 1.2M
- HSTM 186.2K
- Earning Date
- AVXL 08-12-2025
- HSTM 08-04-2025
- Dividend Yield
- AVXL N/A
- HSTM 0.48%
- EPS Growth
- AVXL N/A
- HSTM 14.03
- EPS
- AVXL N/A
- HSTM 0.67
- Revenue
- AVXL N/A
- HSTM $295,211,000.00
- Revenue This Year
- AVXL N/A
- HSTM $5.00
- Revenue Next Year
- AVXL N/A
- HSTM $5.20
- P/E Ratio
- AVXL N/A
- HSTM $38.78
- Revenue Growth
- AVXL N/A
- HSTM 3.50
- 52 Week Low
- AVXL $4.93
- HSTM $25.36
- 52 Week High
- AVXL $14.44
- HSTM $34.24
- Technical
- Relative Strength Index (RSI)
- AVXL 39.87
- HSTM 49.53
- Support Level
- AVXL $9.90
- HSTM $25.91
- Resistance Level
- AVXL $11.70
- HSTM $26.83
- Average True Range (ATR)
- AVXL 0.70
- HSTM 0.57
- MACD
- AVXL -0.23
- HSTM 0.08
- Stochastic Oscillator
- AVXL 1.62
- HSTM 68.90
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.